 |
 |
good summary On 11/5/2015 4:22 PM, Rayilyn Brown wrote: > 1. this cancer drug in low doses yielded dramatic results for a 12 person Phase 1 trial for safety at Georgetown U for people with late stage Parkinson’s. > > 2. It is expensive at $10,000 a month. However, it depends on what kind of insurance u have and whether you live in USA > France or Germany. I will have from CVS/Medicare Part D/SilverScript, 3 month supply for $100 copay. my employer LA City Schools pays insurance company and I pay Medicare. > > 3. at higher than trial doses drug apparently has scary sides like heart problems/sudden death! altho these are seldom mentioned when NPF recommends further study, articles report trial as having established safety, it sounds worse than pd drugs. I had seizures and giant hematomas with ovarian cancer drugs. > > What I don’t know: > > 1. Who is doing further trials? when and where? > 2. What is opinion of neuros? I see mine next week. > 3. How willing is PD community to fight for progress? > and outrageous drug costs/note that drug developer Dr. Druker’s research paid for by Leukemia and Lymphoma Society, not Novartis, drug producer. > > > Ray > Rayilyn Brown > Past Director AZNPF > Arizona Chapter National Parkinson Foundation > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn